Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorRamos Abellán, Hugo
dc.contributor.authorHernandez, Cristina
dc.contributor.authorSimó Canonge, Rafael
dc.contributor.authorSimó-Servat, Olga
dc.date.accessioned2023-06-12T08:04:16Z
dc.date.available2023-06-12T08:04:16Z
dc.date.issued2023-05-15
dc.identifier.citationRamos H, Hernández C, Simó R, Simó-Servat O. Inflammation: The Link between Neural and Vascular Impairment in the Diabetic Retina and Therapeutic Implications. Int J Mol Sci. 2023 May 15;24(10):8796.
dc.identifier.issn1422-0067
dc.identifier.urihttps://hdl.handle.net/11351/9714
dc.descriptionDiabetic retinopathy; Inflammation; Retina
dc.description.abstractThe etiology of diabetic retinopathy (DR) is complex, multifactorial and compromises all the elements of the retinal neurovascular unit (NVU). This diabetic complication has a chronic low-grade inflammatory component involving multiple inflammatory mediators and adhesion molecules. The diabetic milieu promotes reactive gliosis, pro-inflammatory cytokine production and leukocyte recruitment, which contribute to the disruption of the blood retinal barrier. The understanding and the continuous research of the mechanisms behind the strong inflammatory component of the disease allows the design of new therapeutic strategies to address this unmet medical need. In this context, the aim of this review article is to recapitulate the latest research on the role of inflammation in DR and to discuss the efficacy of currently administered anti-inflammatory treatments and those still under development.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesInternational Journal of Molecular Sciences;24(10)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectRetinopatia diabètica
dc.subjectAntiinflamatoris - Ús terapèutic
dc.subject.meshDiabetic Retinopathy
dc.subject.meshAnti-Inflammatory Agents
dc.titleInflammation: The Link between Neural and Vascular Impairment in the Diabetic Retina and Therapeutic Implications
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/ijms24108796
dc.subject.decsretinopatía diabética
dc.subject.decsantiinflamatorios
dc.relation.publishversionhttps://doi.org/10.3390/ijms24108796
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Ramos H, Hernández C, Simó R, Simó-Servat O] Grup de Recerca en Diabetis i Metabolisme, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain
dc.identifier.pmid37240138
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PEICTI2021-2023/PI22%2F01670
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record